Joshua C. Doloff, PhD

Research Interests: Immunoengineering, regenerative medicine, biomaterials/biomedical devices, controlled drug delivery, synthetic and systems biology, and automimmune, cancer, and infectious disease models

Lab Website: Doloff Lab for Immunoengineering & Regenerative Medicine

Publications: From Google Scholar / From Pub Med

Contact

[email protected]

410-614-6479

Smith 5027

Research Interests

Dr. Doloff’s lab in Immunoengineering and Regenerative Medicine is interested in systems biology for understanding tissue dynamics pertaining to immunologic engagement, with applications in biomaterial/biomedical devices, controlled drug delivery systems, and synthetic cellular engineering. Specific emphasis will be applied toward engineering improved therapies in the fields of cancer, autoimmunity and transplantation medicine (i.e. type 1 diabetes), and ophthalmology.

Titles & Affiliations

Titles

Assistant Professor, Biomedical Engineering
Assistant Professor, Materials Science & Engineering
Assistant Professor, Oncology (Cancer Immunology)

Affiliated Centers & Institutes

Translational Tissue Engineering Center

Education

Postdoctoral Fellowship, Langer/Anderson Labs, Koch Institute, MIT, 2011-2018
PhD, Molecular, Cellular Biology & Biochemistry, Boston University, 2011
MA, Molecular, Cellular Biology & Biochemistry, Boston University, 2011
BSE, Bioengineering, University of Pennsylvania, 2004

Faculty News

Recent Highlights

June 24, 2024

Three from Hopkins BME earn Johns Hopkins Catalyst Award

Each honoree will each receive a $75,000 grant to support their work over the next year. They also will have the opportunity to participate in mentoring sessions and events designed to connect them with colleagues at similar stages in their careers.

April 3, 2024

Joshua Doloff receives grant from Ovarian Cancer Research Alliance

Doloff will use funds to expand research in developing strategies for precise ovarian cancer treatment.
January 21, 2022

Tissue Engineering: The Future is Here

Through advances in biomaterials, stem cell science, and more, researchers are moving tantalizingly close to regenerating damaged body parts, creating new organs, and equipping our existing tissues to fight off debilitating diseases.
June 23, 2021

Study suggests that smoother silicone breast implants reduce severity of immune system reactions

According to researchers at Johns Hopkins Medicine, the Massachusetts Institute of Technology, and Rice University, silicone breast implants with a smoother surface design have less risk of producing inflammation and other immune system reactions than those with more roughly textured coatings.